I am an expert in viral hepatitis, other diseases of the liver, and liver transplant, and I direct large clinical trials of a program evaluating novel investigational agents for chronic hepatitis B and C infections. My research interests includes novel approaches to optimizing care delivery for patients with chronic HCV antiviral therapy in special populations.
